ROAM : Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial

Male or<br/>FemaleGender Male or
Female

RecruitingStatus Recruiting

Radiotherapy<br/>TrialTypeRadiotherapy
Trial

UnknownPhase Unknown

18+Age Over 18

Brain and Spinal<br/>CancersCancer LocationBrain and Spinal
Cancers

Radiotherapy | Brain and spinal cordMeningioma

Trial Overview Read MoreRead more

This trial is trying to determine how effective adjuvant fractionated radiotherapy is, in treating newly diagnosed atypical meningioma, in comparison to active monitoring.
 

This trial is treating patients with solitary atypical meningioma .

This is a radiotherapy trial.

You may be able to join this trial if:

  • Your cancer has not spread to other parts of the body.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

  • ISRCTN71502099, EORTC 1308 / TROG 15.02

Scientific Title

Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial

Other Non-Commercial Sponsor

The Walton Centre NHS Foundation Trust (UK)

Summary

The trial will randomise patients who have undergone gross total surgical resection of atypical (grade II) meningioma in a 1:1 ratio to either early radiotherapy (intervention) or active monitoring (comparator). Web-based randomisation will be used in this trial. Patients will be followed up for 60 months post randomisation by collecting information on signs/symptoms of tumour recurrence, 6 monthly MRI, recording of adverse events, quality of life questionnaires and cognitive function tests.

Recruiting Hospitals Read MoreRead more

Peter MacCallum Cancer Centre
Parkville
Ms Lisa Selbie
Lisa.Selbie@petermac.org
(03) 9895 7528

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.

Next